<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03397615</url>
  </required_header>
  <id_info>
    <org_study_id>16</org_study_id>
    <nct_id>NCT03397615</nct_id>
  </id_info>
  <brief_title>Effect of Vaginal Douching With Betadine Before CS for Prevention of Post Operative Infections</brief_title>
  <official_title>Effect of Vaginal Douching With Betadine Versus Non Douching Before CS for Prevention of Post Operative Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study was a prospective randomized controlled trial in which subjects received a
      vaginal preparation with povidone-iodine solution immediately prior to caesarean delivery or
      received no vaginal preparation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present study was a prospective randomized controlled trial in which subjects received a
      vaginal preparation with povidone-iodine solution immediately prior to caesarean delivery or
      received no vaginal preparation
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2018</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postpartum endometritis</measure>
    <time_frame>6 weeks after Cesarean section</time_frame>
    <description>a clinical diagnosis, usually involving fever, uterine fundal tenderness, or prurulent lochia requiring antibiotic therapy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative wound infection</measure>
    <time_frame>6 weeks after Cesarean section</time_frame>
    <description>erythema, tenderness, prurulent drainage from the incision site, with or without fever, requiring antibiotic therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative fever</measure>
    <time_frame>3 weeks after Cesarean section</time_frame>
    <description>temperature higher than 38 degrees C</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Puerperal Infection</condition>
  <arm_group>
    <arm_group_label>Betadine douches</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects received a vaginal preparation with povidone-iodine solution immediately prior to caesarean delivery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non betadine douches</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>subjects didnot received a vaginal preparation prior to caesarean delivery</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Betadine douches</intervention_name>
    <description>subjects received a vaginal preparation with povidone-iodine solution immediately prior to caesarean delivery</description>
    <arm_group_label>Betadine douches</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient undergoing CS

        Exclusion Criteria:

          -  â€¢ Betadine allegy.

               -  Rupture membranes.

               -  Accidental Hemorrhage.

               -  H/O suggestive chorioamnionitis ; uterine tenderness, offensive vaginal
                  discharge, fever medical disorders as diabetes, hypertension , cardiac or renal
                  diseqases
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Maged, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ahmed maged, MD</last_name>
    <phone>+20201005227404</phone>
    <email>dr_ahmedmaged08@kasralainy.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Heba Wagih, MD</last_name>
    <email>heba.wageih@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kasr Alainy medical school</name>
      <address>
        <city>Cairo</city>
        <zip>12151</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2018</study_first_submitted>
  <study_first_submitted_qc>January 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2018</study_first_posted>
  <last_update_submitted>January 6, 2018</last_update_submitted>
  <last_update_submitted_qc>January 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ahmed Maged</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Puerperal Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Povidone-Iodine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

